Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH Meeting
Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced a ...
Archives: Newswire
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug
Humanetics Corporation (Humanetics) announced today that it has entered into a definitive agreement with DSM Nutritional Products Ltd of Kaiseraugst ...
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning
Soligenix, Inc. announced on Feb. 13 that its RiVax® (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication ...
New Technology May Significantly Reduce Diagnostic Time of Coronavirus
Based on a combination of optics and magnetic particles 100 samples of patients potentially infected with the virus can rapidly ...
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses
The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially ...
The Native Antigen Company Introduces Novel Coronavirus Antigens
Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development The ...
Scientists from Noblis and DoD Identify Unique Genetic Sequences of Emerging Coronavirus Threat
Scientists from Noblis and the Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for ...
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2
Vir Biotechnology, Inc., a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, today announced that ...
HHS, Janssen Join Forces On Coronavirus Vaccine
To expedite development of vaccines that protect against the Coronavirus Disease COVID-19 caused by the SARS-CoV-2 virus, the U.S. Department ...
Center for Health Security Announces Emerging Leaders in Biosecurity Initiative Class of 2020
The Johns Hopkins Center for Health Security has accepted 30 professionals and scholars into its Emerging Leaders in Biosecurity Initiative ...
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug ...
Insilico Medicine Publishes Molecular Structures for Key Protein Target of SARS-CoV-2
Insilico Medicine announced today that it will publish structures of small molecules targeting the key protein SARS-CoV-2 (formerly 2019-nCoV) 3C-like ...
Sepsis Alliance and Children’s Hospital Association Release Sepsis: Pediatric First Response Training Module
Today, Sepsis Alliance and the National Association of Emergency Medical Technicians (NAEMT) released the results of their Pediatric Sepsis and ...
CureVac and CEPI Extend Their Cooperation to Develop a Vaccine Against COVID-19
CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, and the Coalition for Epidemic Preparedness Innovations ...
Roche Donates Diagnostics, Medical Supplies for 2019-nCoV
Roche statement on 2019-nCoV (novel coronavirus) Basel, 31 January 2020 The World Health Organization (WHO) has declared a Public Health ...
Red Cross Statement on 2019 Novel Coronavirus
Red Cross Media Statement on 2019 Novel Coronavirus January 31, 2020 At this time, the American Red Cross is ...
Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance
Following extensive support of, and collaboration with, public health professionals in China, Oxford Nanopore has shipped an additional 200 MinION ...
NanoViricides Confirms It Has Been Working On Treatment for Novel Coronavirus
NanoViricides, Inc., a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is ...
UPS To Airlift More Than 2 Million Masks And Protective Gear To China
The UPS Foundation, which leads the global citizenship programs for UPS, announced today it is providing free air transportation of ...
Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics
Mammoth Biosciences, the company behind the world’s first CRISPR-based disease detection platform, today announced an oversubscribed round of $45 million ...
ADVERTISEMENT.
